The average estimate of nine analysts surveyed by Zacks Investment Research was also for earnings of $1.34 per share. The maker of infant formula, medical devices and drugs posted revenue of $10.97 ...

Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus ...

Good morning, and welcome to Procter & Gamble’s Quarter End Conference Call. Today’s event is being recorded for replay. This ...

Financial writer bullish on General Motors' stock, citing strong performance, efficient operations, and potential for future ...

Abbott Laboratories ABT is set to report fourth-quarter fiscal 2024 results on Jan. 22.See the Zacks Earnings Calendar to ...

Brian Martin; Analyst; Janney Montgomery Scott Russell Gunther; Analyst; Stephens Inc.

Cooper Investors, an investment management firm, released its “Cooper Investors Global Equities Fund (Unhedged)” fourth ...

At $45 per share, Macklon had a market cap of $13.5 billion and a price-to-earnings (P/E ... of all a company's shares of stock. The simple formula for enterprise value (EV) is market ...